TABLE 5.
Pearson correlations between reported dietary intake of α-tocopherol or plasma α- and γ-tocopherol concentrations and corresponding tocopherol urinary metabolite concentrations1
| α-CEHC (μmol/g)2 |
α-CMBHC (μmol/g)2 |
γ-CEHC (μmol/g)2 |
||||||||||||||||
| All subjects(n = 233) |
High group3(n = 33) |
Typical group3(n = 200) |
All subjects(n = 233) |
High group3(n = 33) |
Typical group3(n = 200) |
All subjects(n = 233) |
High group3(n = 33) |
Typical group3 (n = 200) |
||||||||||
| R | P | R | P | R | P | R | P | R | P | R | P | R | P | R | P | R | P | |
| Dietary α-tocopherol (mg/d)4 | 0.42 | 0.001 | 0.42 | 0.01 | 0.37 | 0.001 | 0.38 | 0.001 | 0.29 | NS | 0.35 | 0.001 | 0.10 | NS | 0.31 | NS | 0.04 | NS |
| Plasma α-tocopherol (mmol/mol)5 | 0.54 | 0.001 | 0.48 | 0.001 | 0.44 | 0.01 | 0.35 | 0.001 | 0.17 | NS | 0.28 | 0.001 | 0.09 | NS | −0.01 | NS | 0.08 | NS |
| Plasma γ-tocopherol (mmol/mol)5 | −0.45 | 0.001 | −0.39 | 0.02 | −0.44 | 0.001 | −0.27 | 0.001 | −0.20 | NS | −0.28 | 0.001 | 0.05 | NS | −0.10 | NS | 0.09 | NS |
| Dietary α-tocopherol (mg/d)6 | 0.39 | 0.001 | 0.37 | 0.001 | 0.06 | NS | ||||||||||||
| Plasma α-tocopherol (mmol/mol)6 | 0.55 | 0.001 | 0.35 | 0.001 | 0.04 | NS | ||||||||||||
| Plasma γ-tocopherol (mmol/mol)6 | −0.44 | 0.001 | −0.27 | 0.001 | 0.10 | NS | ||||||||||||
Correlations were performed on log-transformed values. CEHC, carboxyethyl hydroxychroman; CMBHC, carboxymethylbutyl hydroxychroman.
Mean of two 24-h urine collections; normalized for creatinine.
Subjects were divided into high or typical grouping based on a plasma α-tocopherol value >33 μmol/L. Those subjects with plasma values >33 μmol/L were placed in the “High” group, and those subjects with plasma values ≤33 μmol/L were placed in the “Typical” group.
Dietary (http://24hrrecall.com); mean of first 6 dietary recalls.
Plasma concentrations were normalized for total cholesterol.
Model adjusted for total plasma cholesterol, plasma triglycerides, BMI, age, sex, race, and energy intake.